Healthcare Services

Lung Cancer Surgery Market Expected to Record Steady Growth and Approach $6.73 Billion by 2030

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Lung Cancer Surgery Market By 2030 Starting From Its 2026 Size?

The market for lung cancer surgery has demonstrated robust growth over recent years. It is anticipated to expand from $5.33 billion in 2025 to $5.6 billion in 2026, indicating a compound annual growth rate (CAGR) of 5.1%. Historically, this expansion has been propelled by several factors, including escalating lung cancer incidence rates, the broadening of hospital surgical capabilities, the availability of proficient thoracic surgeons, the increasing embrace of video-assisted thoracoscopic surgery, and heightened awareness regarding early-stage lung cancer treatment.

The lung cancer surgery market is projected to experience consistent expansion over the coming years, with its value set to reach $6.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This anticipated growth is primarily driven by factors such as the greater integration of robotic surgery platforms, a heightened need for precise surgical results, the proliferation of specialized cancer treatment facilities, increased capital allocation towards surgical innovations, and the wider implementation of enhanced recovery protocols following surgery. Key trends expected during this forecast period encompass the growing adoption of minimally invasive surgical approaches, an uptick in robotic-assisted thoracic surgery, a developing preference for procedures that preserve lung tissue, the expanded use of sophisticated surgical instruments, and an increased emphasis on improving post-operative recovery results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Lung Cancer Surgery Market?

The rising occurrence of lung cancer is anticipated to drive the expansion of the lung cancer surgery market in the foreseeable future. This condition involves the unchecked proliferation of aberrant cells within one or both lungs, disrupting their natural functioning. The elevated incidence of lung cancer stems from extended exposure to air pollution and fine particulate matter; these minute particles can infiltrate deeply into the lungs, resulting in inflammation, cellular harm, and genetic mutations that may trigger cancer formation. Lung cancer surgery plays a crucial role in lowering lung cancer-related mortality by facilitating the prompt removal of malignant tumors before they can disseminate or advance. As an illustration, in June 2025, data from the Centers for Disease Control and Prevention, a US-based federal government agency, indicated that in 2023, lung cancer caused 131,584 deaths in the United States, after 218,893 newly reported cases in 2022. Consequently, the escalating number of lung cancer cases is significantly fueling the expansion of the lung cancer surgery market.

Which Segment Categories Define The Lung Cancer Surgery Market?

The lung cancer surgery market covered in this report is segmented –

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

Which Trends Are Impacting The Growth Of The Lung Cancer Surgery Market?

Leading companies active in the lung cancer surgery market are concentrating on developing pioneering technologies, such as robotic-assisted operations, to elevate surgical precision, decrease recovery periods, and improve patient results. Robotic-assisted surgeries denote minimally invasive procedures executed with robotic systems guided by surgeons to heighten accuracy, mitigate complications, and enhance patient recovery outcomes. For example, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, declared the regulatory clearance of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform offers superior reach and stability to access small, hard-to-reach lung nodules, enhancing the capacity to diagnose lung cancer at earlier stages. Its advanced maneuverability and integration with imaging technologies enable more accurate biopsies while minimizing patient discomfort. Designed to expand procedural capabilities and streamline workflow, the platform fosters greater clinical confidence and consistency across an extensive range of bronchoscopic procedures.

Who Are The Top Companies Competing In The Lung Cancer Surgery Market?

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Read the full lung cancer surgery market report here:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Which Regions Are Projected To Dominate The Lung Cancer Surgery Market In The Coming Years?

North America was the largest region in the lung cancer surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lung Cancer Surgery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25816&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Surgery Market 2026, By The Business Research Company

Lung Cancer Diagnostic And Screening Global Market Report

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Non Small Cell Lung Cancer Nsclc Global Market Report

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Non Small Cell Lung Cancer Nsclc Global Market Report

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795